 |
|
 |
|
|
 |
|||
       |
|||
|
|||
 |
|||
|
|||
Segment Results - 4 th Quarter Fiscal Year 2010
- TECHNE Corporation and Subsidiaries
- Hematology Division
- Biotechnology Division
- R&D Systems Europe (in £'s)
- R&D Systems Europe (in $'s)
- Corporate and Other
(in thousands of $’s, except
per share data)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 66,534 | 65,521 | 70,278 | 66,714 | 269,047 | 100% | (2,790) | 3,645 | 2,412 | 1,824 | 5,091 |
| Cost of sales | 12,901 | 13,329 | 14,399 | 13,834 | 54,463 | 20% | (185) | (101) | 83 | (822) | (1,025) |
| Gross margin | 53,633 | 52,192 | 55,879 | 52,880 | 214,584 | 80% | (2,605) | 3,746 | 2,329 | 2,646 | 6,116 |
| Gross margin percentage | 80.6% | 79.7% | 79.5% | 79.3% | 79.8% | ||||||
| SG&A expense | 8,038 | 9,007 | 7,666 | 7,464 | 32,175 | 12% | (802) | (696) | 605 | (96) | (989) |
| R&D expense | 6,154 | 6,391 | 6,325 | 6,251 | 25,121 | 10% | 244 | 545 | 516 | 252 | 1,557 |
| Amortization expense | 240 | 240 | 240 | 240 | 960 | -- | -- | -- | -- | -- | -- |
| Interest income | (1,168) | (1,156) | (1,040) | (1,011) | (4,375) | (2%) | 1,719 | 1,049 | 464 | 27 | 3,259 |
| Other non-operating ex., net | 662 | 1,011 | 1,249 | 1,335 | 4,257 | 2% | (525) | 299 | 146 | 1,286 | 1,206 |
| 13,926 | 15,493 | 14,440 | 14,279 | 58,138 | 22% | 636 | 1,197 | 1,731 | 1,469 | 5,033 | |
| Earnings before income taxes | 39,707 | 36,699 | 41,439 | 38,601 | 156,446 | 58% | (3,241) | 2,549 | 598 | 1,177 | 1,083 |
| Income taxes | 12,935 | 11,978 | 9,051 | 12,706 | 46,670 | 17% | (1,420) | 1,450 | (4,149) | 668 | (3,451) |
| 26,772 | 24,721 | 32,388 | 25,895 | 109,776 | 41% | (1,821) | 1,099 | 4,747 | 509 | 4,534 | |
| Diluted earnings per share | .72 | .66 | .87 | .69 | 2.94 | ||||||
| Weighted average diluted shares outstanding | 37,339 | 37,353 | 37,380 | 37,314 | 37,347 | ||||||
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 4,668 | 4,325 | 4,938 | 4,463 | 18,394 | 100% | 422 | 65 | 504 | (99) | 892 |
| Cost of sales | 2,319 | 2,292 | 2,505 | 2,503 | 9,619 | 52% | (50) | (113) | 180 | 134 | 151 |
| Gross margin | 2,349 | 2,033 | 2,433 | 1,960 | 8,775 | 48% | 472 | 178 | 324 | (233) | 741 |
| Gross margin percentage | 50.3% | 47.0% | 49.3% | 43.9% | 47.7% | ||||||
| SG&A expense | 370 | 366 | 346 | 311 | 1,393 | 8% | (66) | (32) | 36 | (8) | (70) |
| R&D expense | 198 | 201 | 198 | 193 | 790 | 4% | 5 | (2) | 11 | 4 | 18 |
| Interest, net | (72) | (72) | (65) | (68) | (277) | (1%) | 30 | 19 | 15 | 4 | 68 |
| 496 | 495 | 479 | 436 | 1,906 | 11% | (31) | (15) | 62 | 0 | 16 | |
| Pretax result | 1,853 | 1,538 | 1,954 | 1,524 | 6,869 | 37% | 503 | 193 | 262 | (233) | 725 |
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 51,696 | 50,703 | 54,236 | 53,032 | 209,667 | 100% | (2,203) | 2,060 | 518 | 3,298 | 3,673 |
| Intersegment sales | (7,668) | (8,282) | (8,057) | (7,771) | (31,778) | 94 | 29 | 522 | (342) | 303 | |
| 44,028 | 42,421 | 46,179 | 45,261 | 177,889 | (2,109) | 2,089 | 1,040 | 2,956 | 3,976 | ||
| Cost of sales | 9,885 | 10,126 | 11,159 | 10,569 | 41,739 | 20% | (362) | (964) | 79 | 258 | (989) |
| Intersegment sales | (7,598) | (7,753) | (8,336) | (7,857) | (31,544) | (137) | 586 | 158 | (403) | 204 | |
| 2,287 | 2,373 | 2,823 | 2,712 | 10,195 | (499) | (378) | 237 | (145) | (785) | ||
| Gross margin | 41,741 | 40,048 | 43,356 | 42,549 | 167,694 | 80% | (1,610) | 2,467 | 803 | 3,101 | 4,761 |
| Gross margin percentage | 80.9% | 80.0% | 79.4% | 80.1% | 80.1% | ||||||
| SG&A expense | 4,734 | 5,056 | 4,625 | 4,532 | 18,947 | 9% | (407) | (362) | 363 | 318 | (88) |
| R&D expense | 5,956 | 6,190 | 6,127 | 6,058 | 24,331 | 12% | 239 | 547 | 505 | 248 | 1,539 |
| Amortization expense | 240 | 240 | 240 | 240 | 960 | -- | -- | -- | -- | -- | -- |
| Interest, net | (771) | (772) | (706) | (733) | (2,982) | (1%) | 313 | 198 | 147 | 10 | 668 |
| Other expense | 2 | 1 | -- | (2) | 1 | -- | 4 | -- | (1) | (4) | (1) |
| 10,161 | 10,715 | 10,286 | 10,095 | 41,257 | 20% | 149 | 383 | 1,014 | 572 | 2,118 | |
| Pretax result | 31,580 | 29,333 | 33,070 | 32,454 | 126,437 | 60% | (1,759) | 2,084 | (211) | 2,529 | 2,643 |
(1) Includes R&D Systems' Biotechnology Division, BiosPacific, Inc. and R&D China
Back to Top
(in thousands of £'s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 10,881 | 11,462 | 12,296 | 11,403 | 46,042 | 100% | 706 | 265 | (420) | 269 | 820 |
| Cost of sales | 5,061 | 5,288 | 5,824 | 5,785 | 21,958 | 48% | 801 | (73) | (716) | 102 | 114 |
| Gross margin | 5,820 | 6,174 | 6,472 | 5,618 | 24,084 | 52% | (95) | 338 | 296 | 167 | 706 |
| Gross margin percentage | 53.5% | 53.9% | 52.6% | 49.3% | 52.3% | ||||||
| SG&A expense | 1,191 | 1,318 | 1,260 | 1,315 | 5,084 | 11% | (33) | (46) | 69 | 127 | 117 |
| Interest income | (87) | (79) | (68) | (38) | (272) | -- | 703 | 504 | 167 | 64 | 1,438 |
| Exchange loss/(gain) | (89) | 61 | 237 | 428 | 637 | 1% | (349) | 96 | 74 | 796 | 617 |
| 1,015 | 1,300 | 1,429 | 1,705 | 5,449 | 12% | 321 | 554 | 310 | 987 | 2,172 | |
| Pretax result | 4,805 | 4,874 | 5,043 | 3,913 | 18,635 | 40% | (416) | (216) | (14) | (820) | (1,466) |
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | Percent Of Sales |
First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Sales | 17,838 | 18,775 | 19,161 | 16,990 | 72,764 | 100% | (1,103) | 1,491 | 868 | (1,033) | 223 |
| Cost of sales | 8,295 | 8,664 | 9,071 | 8,619 | 34,649 | 48% | 364 | 390 | (334) | (811) | (391) |
| Gross margin | 9,543 | 10,111 | 10,090 | 8,371 | 38,115 | 52% | (1,467) | 1,101 | 1,202 | (222) | 614 |
| Gross margin percentage | 53.5% | 53.9% | 52.7% | 49.3% | 52.4% | ||||||
| SG&A expense | 1,952 | 2,159 | 1,967 | 1,961 | 8,039 | 11% | (331) | 65 | 253 | 85 | 72 |
| Interest income | (143) | (128) | (108) | (57) | (436) | -- | 1,328 | 778 | 230 | (29) | 2,307 |
| Exchange loss | (145) | 99 | 372 | 633 | 959 | 1% | (621) | 94 | 134 | 1,320 | 927 |
| 1,664 | 2,130 | 2,231 | 2,537 | 8,562 | 12% | 376 | 937 | 617 | 1,376 | 3,306 | |
| Pretax result | 7,879 | 7,981 | 7,859 | 5,834 | 29,553 | 40% | (1,843) | 164 | 585 | (1,598) | (2,692) |
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | |||||||||
| First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | First Quarter |
Second Quarter |
Third Quarter |
Fourth Quarter |
YTD | |
| Interest income | 182 | 184 | 161 | 153 | 680 | (48) | (54) | (72) | (42) | (216) |
| Rental income | 81 | 115 | 83 | 134 | 413 | (18) | (16) | (32) | (2) | (68) |
| 263 | 299 | 244 | 287 | 1,093 | (66) | (70) | (104) | (44) | (284) | |
| SG&A expense | 982 | 1,426 | 728 | 660 | 3,796 | 2 | (367) | (47) | (491) | (903) |
| Other-Building expenses | 548 | 530 | 593 | 529 | 2,200 | (5) | (21) | 20 | (2) | (8) |
| Other-Equity Investment losses | 338 | 496 | 367 | 309 | 1,510 | 79 | 210 | (39) | (30) | 220 |
| 1,868 | 2,452 | 1,688 | 1,498 | 7,506 | 76 | (178) | (66) | (523) | (691) | |
| Pretax result | (1,605) | (2,153) | (1,444) | (1,211) | (6,413) | (142) | 108 | (38) | 479 | 407 |
Back to Top
|
Home -
Company News -
Financial Information -
About TECHNE -
Map/Directions -
Products -
Contact Us
TECHNE CORPORATION 614 McKinley Place N.E. Minneapolis, MN 55413-2610 Phone: (612)379-8854 Fax: (612)379-6580 e-mail: techinfo@techne-corp.com * Up to a 15 minute delay on Market Overview. Please consult your financial advisor for an up-to-minute quote. Quote provided by Barchart.com. |